Company / Return on Equity (ROE)
PULSE BIOSCIENCES, INC. Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-90.2%
FY2025
5-year range
-178.4% / -46.7%
FY2021-FY2025
Trend
-93.4%
vs FY2024
Sector context
#145 of 148
Health Care
What the data says
PULSE BIOSCIENCES, INC. reports negative total equity of -90.2% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-90.2% in FY2025 with a 5-year CAGR of +127.5%.
Improved from -163.9% to -90.2% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- +127.5pp
- 10-Year Change
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 148This company -90.2% Sector average -3.2%
▼
-2757.3% below sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 93.4% year-over-year.
- Currently 87.1pp below the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2016.
- Lowest return on equity (roe) in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -90.2% | -93.4% |
| FY2024 | -46.7% | +71.5% |
| FY2023 | -163.9% | - |
| FY2022 | - | - |
| FY2021 | -178.4% | +18.1% |
| FY2020 | -217.8% | -42.5% |
| FY2019 | -152.8% | -170.0% |
| FY2018 | -56.6% | -1.8% |
| FY2017 | -55.6% | -47.8% |
| FY2016 | -37.6% | -82.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026